Authors: Abbott|, Natalie(1)*[natalie.abbott@wales.nhs.uk];Robinson|, Maxwell(2);Copeland|, Joanne(3);Harrison|, Mark(4);Hawkins|, Maria(5);Muirhead|, Rebecca(2);Adams|, Richard(6);Sebag-Montefiore|, David(7);
(1)RTTQA group- Velindre Cancer Centre, Medical Physics, Cardiff, United Kingdom;(2)Oxford University Hospitals NHS Trust, o, Oxford, United Kingdom;(3)Leeds University, Leeds Clinical Trials Research Unit, Leeds, United Kingdom;(4)Mount Vernon Hospital, Mount Vernon Centre for Cancer, Northwood, United Kingdom;(5)University College London, UcL, London, United Kingdom;(6)Cardiff University Department of Cancer & Genetics, and Velindre Cancer Centre, Cardiff, United Kingdom;(7)St James University Hospital, Leeds Cancer Centre, Leeds, United Kingdom;
Show Affiliations
Hide Affiliations